Roles of P67/MetAP2 as a tumor suppressor.

[1]  Hana Kovarova,et al.  Protein signaling pathways in differentiation of neural stem cells , 2008, Proteomics.

[2]  Jennifer F. Raven,et al.  Stat1 Phosphorylation Determines Ras Oncogenicity by Regulating p27Kip1 , 2008, PloS one.

[3]  S. Davidsen,et al.  Ectopic expression of methionine aminopeptidase-2 causes cell transformation and stimulates proliferation , 2008, Oncogene.

[4]  A. Tischler,et al.  Metastasis‐associated gene expression profile of liver and subcutaneous lesions derived from mouse pheochromocytoma cells , 2008, Molecular carcinogenesis.

[5]  R. Kaufman,et al.  MEK Signaling Is Required for Phosphorylation of eIF2α following Amino Acid Limitation of HepG2 Human Hepatoma Cells* , 2008, Journal of Biological Chemistry.

[6]  Qian Zhang,et al.  Correlation of tumor growth suppression and methionine aminopetidase-2 activity blockade using an orally active inhibitor , 2008, Proceedings of the National Academy of Sciences.

[7]  D. Essex,et al.  Methionine aminopeptidase-2 blockade reduces chronic collagen-induced arthritis: potential role for angiogenesis inhibition , 2007, Arthritis research & therapy.

[8]  B. Lefkove,et al.  Fumagillin: an anti-infective as a parent molecule for novel angiogenesis inhibitors , 2007, Expert review of anti-infective therapy.

[9]  A. Bode,et al.  Involvement of ERKs, RSK2 and PKR in UVA-induced signal transduction toward phosphorylation of eIF2alpha (Ser(51)). , 2007, Carcinogenesis.

[10]  Wei Chen,et al.  Differential regulation and properties of MAPKs , 2007, Oncogene.

[11]  A. Borczuk,et al.  Methionine aminopeptidase-2 as a selective target of myofibroblasts in pulmonary fibrosis. , 2007, American journal of respiratory cell and molecular biology.

[12]  G. Hannig,et al.  Suppression of inflammation and structural damage in experimental arthritis through molecular targeted therapy with PPI-2458. , 2007, Arthritis and rheumatism.

[13]  Arnab Ghosh,et al.  Autoproteolysis of rat p67 generates several peptide fragments: the N-terminal fragment, p26, is required for the protection of eIF2alpha from phosphorylation. , 2007, Biochemistry.

[14]  G. Riggins,et al.  Methionine aminopeptidase 2 over-expressed in cholangiocarcinoma: Potential for drug target , 2007, Acta oncologica.

[15]  D. Ron,et al.  13 eIF2α Phosphorylation in Cellular Stress Responses and Disease , 2007 .

[16]  A. Hinnebusch,et al.  9 Mechanism of Translation Initiation in the Yeast Saccharomyces cerevisiae , 2007 .

[17]  Michael B. Mathews,et al.  Translational control in biology and medicine , 2007 .

[18]  M. Mathews,et al.  20 Protein Synthesis and Translational Control during Viral Infection , 2007 .

[19]  Arnab Ghosh,et al.  The N-terminal lysine residue-rich domain II and the 340-430 amino acid segment of eukaryotic initiation factor 2-associated glycoprotein p67 are the binding sites for the gamma-subunit of eIF2. , 2006, Experimental cell research.

[20]  Arnab Ghosh,et al.  The binding between p67 and eukaryotic initiation factor 2 plays important roles in the protection of eIF2alpha from phosphorylation by kinases. , 2006, Archives of biochemistry and biophysics.

[21]  Cathleen Brdlik,et al.  Targeted gene disruption of methionine aminopeptidase 2 results in an embryonic gastrulation defect and endothelial cell growth arrest , 2006, Proceedings of the National Academy of Sciences.

[22]  C. D. Thompson,et al.  Inhibition of melanoma tumor growth by a pharmacological inhibitor of MetAP-2, PPI-2458. , 2006, International journal of oncology.

[23]  D. Gutmann,et al.  Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma. , 2005, Cancer research.

[24]  A. Levitzki,et al.  Activation of dsRNA dependent protein kinase PKR in Karpas299 does not lead to cell death , 2005, Cancer biology & therapy.

[25]  Arnab Ghosh,et al.  The stability of eukaryotic initiation factor 2-associated glycoprotein, p67, increases during skeletal muscle differentiation and that inhibits the phosphorylation of extracellular signal-regulated kinases 1 and 2. , 2005, Experimental cell research.

[26]  R. Wek,et al.  GCN2 phosphorylation of eIF2a activates NF-?B in response to UV irradiation , 2005 .

[27]  R. Balusu,et al.  Treatment of cells with the angiogenic inhibitor fumagillin results in increased stability of eukaryotic initiation factor 2-associated glycoprotein, p67, and reduced phosphorylation of extracellular signal-regulated kinases. , 2004, Biochemistry.

[28]  M. Boxem,et al.  The C. elegans methionine aminopeptidase 2 analog map‐2 is required for germ cell proliferation , 2004, FEBS letters.

[29]  J. Dimmock,et al.  Expression of methionine aminopeptidase 2, N-myristoyltransferase, and N-myristoyltransferase inhibitor protein 71 in HT29. , 2004, Biochemical and biophysical research communications.

[30]  C. D. Thompson,et al.  A methionine aminopeptidase-2 inhibitor, PPI-2458, for the treatment of rheumatoid arthritis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Arnab Ghosh,et al.  Eukaryotic initiation factor 2-associated glycoprotein, p67, shows differential effects on the activity of certain kinases during serum-starved conditions. , 2004, Archives of biochemistry and biophysics.

[32]  L. Honigberg,et al.  Design and synthesis of beta-amino-alpha-hydroxy amide derivatives as inhibitors of MetAP2 and HUVEC growth. , 2004, Bioorganic & medicinal chemistry letters.

[33]  Yuji Kurihara,et al.  Effect of ionizing irradiation on human esophageal cancer cell lines by cDNA microarray gene expression analysis. , 2004, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[34]  J. Dimmock,et al.  High Expression of Methionine Aminopeptidase 2 in Human Colorectal Adenocarcinomas , 2004, Clinical Cancer Research.

[35]  M. Karin,et al.  The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4 , 2004, Nature.

[36]  Scott A. Erickson,et al.  3-Amino-2-hydroxyamides and related compounds as inhibitors of methionine aminopeptidase-2. , 2004, Bioorganic & medicinal chemistry letters.

[37]  D. Ludovici,et al.  Small molecule inhibitors of methionine aminopeptidase type 2 (MetAP-2) fail to inhibit endothelial cell proliferation or formation of microvessels from rat aortic rings in vitro , 2004, Angiogenesis.

[38]  Scott A. Erickson,et al.  Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2. , 2003, Cancer research.

[39]  Yie-Hwa Chang,et al.  N‐terminal methionine removal and methionine metabolism in Saccharomyces cerevisiae , 2003, Journal of cellular biochemistry.

[40]  D. Egan,et al.  Physiologically relevant metal cofactor for methionine aminopeptidase-2 is manganese. , 2003, Biochemistry.

[41]  B. Datta,et al.  Mutation at the acidic residue-rich domain of eukaryotic initiation factor 2 (eIF2alpha)-associated glycoprotein p67 increases the protection of eIF2alpha phosphorylation during heat shock. , 2003, Archives of biochemistry and biophysics.

[42]  Arnab Ghosh,et al.  A glycosylation site, 60SGTS63, of p67 is required for its ability to regulate the phosphorylation and activity of eukaryotic initiation factor 2alpha. , 2003, Biochemistry.

[43]  R. Tammali,et al.  Negative regulation of the protection of eIF2alpha phosphorylation activity by a unique acidic domain present at the N-terminus of p67. , 2003, Experimental cell research.

[44]  M. Mathews,et al.  Neoplastic progression in melanoma and colon cancer is associated with increased expression and activity of the interferon-inducible protein kinase, PKR , 2002, Oncogene.

[45]  F. Khuri,et al.  Safety and pharmacokinetic effects of TNP-470, an angiogenesis inhibitor, combined with paclitaxel in patients with solid tumors: evidence for activity in non-small-cell lung cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  B. Matthews,et al.  Metalloaminopeptidases: common functional themes in disparate structural surroundings. , 2002, Chemical reviews.

[47]  R. Bradshaw,et al.  Methionine aminopeptidases and angiogenesis. , 2002, Essays in biochemistry.

[48]  A. Gingras,et al.  Activation of GCN2 in UV-Irradiated Cells Inhibits Translation , 2002, Current Biology.

[49]  Yie-Hwa Chang,et al.  Functional expression of human methionine aminopeptidase type 1 in Saccharomyces cerevisiae. , 2002, Protein and peptide letters.

[50]  M. Fukayama,et al.  High Expression of Methionine Aminopeptidase Type 2 in Germinal Center B Cells and Their Neoplastic Counterparts , 2002, Laboratory Investigation.

[51]  R. Kaufman,et al.  Ultraviolet Light Inhibits Translation through Activation of the Unfolded Protein Response Kinase PERK in the Lumen of the Endoplasmic Reticulum* , 2002, The Journal of Biological Chemistry.

[52]  J. Widom,et al.  Crystal Structure of the N-terminal Segment of Human Eukaryotic Translation Initiation Factor 2α* , 2002, The Journal of Biological Chemistry.

[53]  Joseph A. Vetro,et al.  The specificity in vivo of two distinct methionine aminopeptidases in Saccharomyces cerevisiae. , 2002, Archives of biochemistry and biophysics.

[54]  X. Su,et al.  Angiogenesis inhibitors specific for methionine aminopeptidase 2 as drugs for malaria and leishmaniasis. , 2002 .

[55]  Joseph A. Vetro,et al.  Yeast methionine aminopeptidase type 1 is ribosome‐associated and requires its N‐terminal zinc finger domain for normal function in vivo * , 2002, Journal of cellular biochemistry.

[56]  Y. Zhou,et al.  Protection of translation initiation factor eIF2 phosphorylation correlates with eIF2-associated glycoprotein p67 levels and requires the lysine-rich domain I of p67. , 2001, Biochimie.

[57]  M. Doyle,et al.  Steady-state kinetic characterization of substrates and metal-ion specificities of the full-length and N-terminally truncated recombinant human methionine aminopeptidases (type 2). , 2001, Biochemistry.

[58]  L. Strizzi,et al.  Methionine aminopeptidase-2 regulates human mesothelioma cell survival: role of Bcl-2 expression and telomerase activity. , 2001, The American journal of pathology.

[59]  R. Deshaies,et al.  Protacs: Chimeric molecules that target proteins to the Skp1–Cullin–F box complex for ubiquitination and degradation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[60]  C. Logothetis,et al.  Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[61]  G. Hart,et al.  Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins , 2001, The Journal of Biological Chemistry.

[62]  A. Tischler,et al.  Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice , 2000, Cell and Tissue Research.

[63]  C. Crews,et al.  The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[64]  M. Mathews,et al.  Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR , 2000, Oncogene.

[65]  Eric C. Griffith,et al.  Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[66]  J. Henkin,et al.  Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases , 2000, Journal of cellular biochemistry.

[67]  B. Datta.  MAPs and POEP of the roads from prokaryotic to eukaryotic kingdoms. , 2000, Biochimie.

[68]  R. Schneider.  17 Translational Control during Heat Shock , 2000 .

[69]  Jane-Jane Chen.  14 Heme-regulated eIF2α Kinase , 2000 .

[70]  N. Sonenberg,et al.  Translational control of gene expression , 2000 .

[71]  K. Biemann,et al.  Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells. , 1999, Chemistry & biology.

[72]  S. Mukherjee,et al.  Increased phosphorylation of eukaryotic initiation factor 2alpha at the G2/M boundary in human osteosarcoma cells correlates with deglycosylation of p67 and a decreased rate of protein synthesis. , 1999, Experimental cell research.

[73]  U. Gaul,et al.  A methionine aminopeptidase and putative regulator of translation initiation is required for cell growth and patterning in Drosophila , 1999, Mechanisms of Development.

[74]  B. Datta,et al.  Induction of apoptosis due to lowering the level of eukaryotic initiation factor 2-associated protein, p67, from mammalian cells by antisense approach. , 1999, Experimental cell research.

[75]  Eric C. Griffith,et al.  Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[76]  J. Widom,et al.  Structure of human methionine aminopeptidase-2 complexed with fumagillin. , 1998, Science.

[77]  A. Bose,et al.  Viral infection. II. Hemin induces overexpression of p67 as it partially prevents appearance of an active p67-deglycosylase in baculovirus-infected insect cells. , 1997, Archives of biochemistry and biophysics.

[78]  A. Bose,et al.  Viral Infection , 2020, Definitions.

[79]  K. Biemann,et al.  Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. , 1997, Chemistry & biology.

[80]  V. Castronovo,et al.  TNP-470 (AGM-1470): mechanisms of action and early clinical development. , 1996, European journal of cancer.

[81]  X Li,et al.  Amino-terminal protein processing in Saccharomyces cerevisiae is an essential function that requires two distinct methionine aminopeptidases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[82]  R A Bradshaw,et al.  Eukaryotic methionyl aminopeptidases: two classes of cobalt-dependent enzymes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[83]  Y. Chang,et al.  Molecular cloning of a human complementary DNA encoding an initiation factor 2-associated protein (p67). , 1995, Biochimica et biophysica acta.

[84]  Q. Guo,et al.  A protease assay via precolumn derivatization and high-performance liquid chromatography. , 1994, Analytical biochemistry.

[85]  W. Zhou,et al.  A fumagillin derivative angiogenesis inhibitor, AGM-1470, inhibits activation of cyclin-dependent kinases and phosphorylation of retinoblastoma gene product but not protein tyrosyl phosphorylation or protooncogene expression in vascular endothelial cells. , 1994, Cancer research.

[86]  A. Bose,et al.  Regulation of eIF-2 alpha-subunit phosphorylation in reticulocyte lysate. , 1994, Biochemistry.

[87]  V. Castronovo,et al.  AGM-1470, a potent angiogenesis inhibitor, prevents the entry of normal but not transformed endothelial cells into the G1 phase of the cell cycle. , 1994, Cancer research.

[88]  R. Panniers.  Translational control during heat shock. , 1994, Biochimie.

[89]  K. Sudo,et al.  Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470 (AGM-1470). , 1994, Anticancer research.

[90]  K. Tanaka,et al.  Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. , 1993, Cancer research.

[91]  D. Chakrabarti,et al.  Cloning and characterization of complementary DNA encoding the eukaryotic initiation factor 2-associated 67-kDa protein (p67). , 1993, The Journal of biological chemistry.

[92]  A. Bose,et al.  Characteristics of the eukaryotic initiation factor 2 associated 67-kDa polypeptide. , 1993, Biochemistry.

[93]  B. Matthews,et al.  Structure of the cobalt-dependent methionine aminopeptidase from Escherichia coli: a new type of proteolytic enzyme. , 1993, Biochemistry.

[94]  R A Bradshaw,et al.  Isolation and characterization of the methionine aminopeptidase from porcine liver responsible for the co-translational processing of proteins. , 1992, The Journal of biological chemistry.

[95]  J. Smith,et al.  Molecular cloning, sequencing, deletion, and overexpression of a methionine aminopeptidase gene from Saccharomyces cerevisiae. , 1992, The Journal of biological chemistry.

[96]  N. Gupta,et al.  The eukaryotic initiation factor 2-associated 67-kDa polypeptide (p67) plays a critical role in regulation of protein synthesis initiation in animal cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[97]  D. Ingber,et al.  Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. , 1991, Biochemical and biophysical research communications.

[98]  D. Ingber,et al.  Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth , 1990, Nature.

[99]  J. Smith,et al.  Purification and characterization of a methionine aminopeptidase from Saccharomyces cerevisiae. , 1990, The Journal of biological chemistry.

[100]  Margaret Robertson,et al.  The neurofibromatosis type 1 gene encodes a protein related to GAP , 1990, Cell.

[101]  D. Chakrabarti,et al.  Glycosylation of eukaryotic peptide chain initiation factor 2 (eIF-2)-associated 67-kDa polypeptide (p67) and its possible role in the inhibition of eIF-2 kinase-catalyzed phosphorylation of the eIF-2 alpha-subunit. , 1989, The Journal of biological chemistry.

[102]  G. Hart,et al.  Nuclear and cytoplasmic glycosylation: novel saccharide linkages in unexpected places. , 1988, Trends in biochemical sciences.

[103]  D. Towler,et al.  Amino-terminal processing of proteins by N-myristoylation. Substrate specificity of N-myristoyl transferase. , 1987, The Journal of biological chemistry.

[104]  G. Hart,et al.  The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc. , 1986, The Journal of biological chemistry.

[105]  J. Warner,et al.  The ribosomal proteins of Saccharomyces cerevisiae. Phosphorylated and exchangeable proteins. , 1976, The Journal of biological chemistry.